Dongare Shirish, Gupta Suresh K, Mathur Rajani, Saxena Rohit, Mathur Sandeep, Agarwal Renu, Nag Tapas C, Srivastava Sushma, Kumar Pankaj
Ocular Pharmacology Laboratory, Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India.
Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Mol Vis. 2016 Jun 9;22:599-609. eCollection 2016.
Diabetic retinopathy is a common microvascular complication of long-standing diabetes. Several complex interconnecting biochemical pathways are activated in response to hyperglycemia. These pathways culminate into proinflammatory and angiogenic effects that bring about structural and functional damage to the retinal vasculature. Since Zingiber officinale (ginger) is known for its anti-inflammatory and antiangiogenic properties, we investigated the effects of its extract standardized to 5% 6-gingerol, the major active constituent of ginger, in attenuating retinal microvascular changes in rats with streptozotocin-induced diabetes.
Diabetic rats were treated orally with the vehicle or the ginger extract (75 mg/kg/day) over a period of 24 weeks along with regular monitoring of bodyweight and blood glucose and weekly fundus photography. At the end of the 24-week treatment, the retinas were isolated for histopathological examination under a light microscope, transmission electron microscopy, and determination of the retinal tumor necrosis factor-α (TNF-α), nuclear factor-kappa B (NF-κB), and vascular endothelial growth factor (VEGF) levels.
Oral administration of the ginger extract resulted in significant reduction of hyperglycemia, the diameter of the retinal vessels, and vascular basement membrane thickness. Improvement in the architecture of the retinal vasculature was associated with significantly reduced expression of NF-κB and reduced activity of TNF-α and VEGF in the retinal tissue in the ginger extract-treated group compared to the vehicle-treated group.
The current study showed that ginger extract containing 5% of 6-gingerol attenuates the retinal microvascular changes in rats with streptozotocin-induced diabetes through anti-inflammatory and antiangiogenic actions. Although precise molecular targets remain to be determined, 6-gingerol seems to be a potential candidate for further investigation.
糖尿病视网膜病变是长期糖尿病常见的微血管并发症。高血糖会激活多个复杂且相互关联的生化途径。这些途径最终导致促炎和促血管生成效应,对视网膜血管造成结构和功能损伤。由于姜以其抗炎和抗血管生成特性而闻名,我们研究了标准化为含5% 6 - 姜酚(姜的主要活性成分)的姜提取物对链脲佐菌素诱导的糖尿病大鼠视网膜微血管变化的缓解作用。
糖尿病大鼠连续24周口服赋形剂或姜提取物(75毫克/千克/天),同时定期监测体重和血糖,并每周进行眼底摄影。在24周治疗结束时,分离视网膜进行光学显微镜下的组织病理学检查、透射电子显微镜检查,并测定视网膜肿瘤坏死因子-α(TNF-α)、核因子-κB(NF-κB)和血管内皮生长因子(VEGF)水平。
口服姜提取物可显著降低高血糖、视网膜血管直径和血管基底膜厚度。与赋形剂治疗组相比,姜提取物治疗组视网膜血管结构的改善与视网膜组织中NF-κB表达显著降低、TNF-α和VEGF活性降低有关。
本研究表明,含5% 6 - 姜酚的姜提取物通过抗炎和抗血管生成作用减轻链脲佐菌素诱导的糖尿病大鼠的视网膜微血管变化。尽管确切的分子靶点仍有待确定,但6 - 姜酚似乎是进一步研究的潜在候选物。